News

An antibody that can fight all types of the influenza A virus has been identified by researchers from the Medical Research Council's National Institute for Medical Research. Studies in fly-infected mice showed that the antibody could...

GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Potiga™ (ezogabine) Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older. ...

Paladin Labs Inc., a leading Canadian specialty pharmaceutical company, today announced that they have entered into a licensing and distribution agreement under which Paladin has been granted exclusive Canadian rights from an affiliate of Elan Corporation,.. ...

Merck appreciates the U.S. Food and Drug Administration's (FDA) recognition of our efforts to create new standardized product packaging for several of our medicines. These changes to the packaging of several medicines were made by Merck...

Forest Laboratories, Inc. announced today that Daliresp(TM) (roflumilast) will be available in pharmacies throughout the United States by mid-June. The U.S. Food and Drug Administration (FDA) recently approved Daliresp as a treatment to reduce the risk...

Novagali Pharma, a pharmaceutical company that develops innovative ophthalmic products, can today announce that it has signed an exclusive agreement with Ardeo Health, LLC for Nova23041 its unique formulation for thetreatment of dry eye symptoms in the United States...

Synthes, Inc. and Eli Lilly and Company announced the signing of an exclusive worldwide collaboration agreement to address the needs of patients who are cared for by orthopedic surgeons, including those with osteoporosis and those with bone fractures. ...